Design: Curran & Connors, San Francisco
2008 Annual Report
Our ongoing efforts to expand our peripheral and neurovascular businesses have resulted in advancements in all of our major product categories. Today we are uniquely positioned as the only company providing a full complement of endovascular technologies to treat neurovascular and peripheral artery disease, depending on a patientís condition and physician preference. These important accomplishments have positioned ev3 to achieve its vision to be the best at identifying and treating lower extremity arterial and neurovascular disease, leading with breakthrough technologies and processes.
Download PDF (1 MB)